Implantable Device
Top in cardiology: Hostility at work, FDA warning on cell phones and cardiac devices
New survey results show that nearly half of cardiologists experienced a hostile work environment. More women than men reported hostility, including harassment and discrimination. It was the top story in cardiology last week.
FDA warns certain cell phones, smartwatches may interfere with implanted medical devices
The FDA issued a warning that certain cell phones and smartwatches containing high field strength magnets may cause some implanted medical devices, particularly cardiac devices, to suspend normal operations when in proximity to the magnet.
Recall of ventricular assist device implant kit designated Class I
The FDA has identified Medtronic’s recall of its ventricular assist device implant kit as Class I recall, the most serious type, due to risk for serious injuries or death.
Cardiac monitor insertion after cryptogenic stroke may be cost-effective in US
Immediate insertion of a cardiac monitor following first cryptogenic stroke was cost-effective in the U.S. compared with delayed implantation after 30-day Holter monitoring, according to a study.
Personalized risk assessment may predict ICD benefit
The risk for ventricular tachyarrhythmic events weighted against the risk for nonarrhythmic mortality predicted the likely benefit of implantable cardioverter defibrillators, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions.
Leadless pacemaker confers similar complications, survival at 30 days as transvenous device
Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions.
Top news in cardiac technology: Remote monitoring, Apple Heart Study and more
Healio and Cardiology Today present the top stories in cardiac technology. Our readers were most interested in remote monitoring, implantable LVADs and the latest research from the Apple Heart Study.
Implantable cardiac device infections affect cost, quality of life, mortality
PHILADELPHIA — In a new analysis from the WRAP-IT trial, patients with cardiac implantable electronic devices, or CIEDs, who had major infections from their devices had higher rates of mortality, higher costs and worse quality of life compared with those who did not.
Risk score may predict need for pacemaker after TAVR
Researchers have developed and validated the Emory risk score as a tool for predicting patients’ need for pacemaker implantation after transcatheter aortic valve replacement, according to findings published in JACC: Cardiovascular Intervention.
Two-lead version of implantable pulse generator for HF garners approval
Impulse Dynamics announced that a two-lead version of its implantable pulse generator to deliver cardiac contractility modulation therapy to patients with HF has been approved by the FDA.